Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes.
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
21
02
2022
accepted:
03
10
2023
medline:
17
11
2023
pubmed:
8
11
2023
entrez:
8
11
2023
Statut:
ppublish
Résumé
Rheumatoid arthritis is a prototypical autoimmune disease that causes joint inflammation and destruction
Identifiants
pubmed: 37938773
doi: 10.1038/s41586-023-06708-y
pii: 10.1038/s41586-023-06708-y
pmc: PMC10651487
doi:
Substances chimiques
Cytokines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
616-624Subventions
Organisme : NIAMS NIH HHS
ID : UH2 AR067685
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067681
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067689
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067694
Pays : United States
Organisme : NIAMS NIH HHS
ID : K08 AR077037
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI148435
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067679
Pays : United States
Organisme : NIAMS NIH HHS
ID : UM2 AR067678
Pays : United States
Organisme : NIAMS NIH HHS
ID : P30 AR069655
Pays : United States
Organisme : NIAMS NIH HHS
ID : R21 AR071670
Pays : United States
Organisme : NIAMS NIH HHS
ID : K08 AR081412
Pays : United States
Organisme : NIAMS NIH HHS
ID : T32 AR007258
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001866
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR073290
Pays : United States
Organisme : NHGRI NIH HHS
ID : T32 HG002295
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007753
Pays : United States
Organisme : NIAMS NIH HHS
ID : T32 AR007530
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR073833
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067688
Pays : United States
Organisme : NIAMS NIH HHS
ID : K08 AR072791
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR063759
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067690
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG009379
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067677
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067676
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067691
Pays : United States
Investigateurs
Jennifer Albrecht
(J)
Jennifer L Barnas
(JL)
Joan M Bathon
(JM)
David L Boyle
(DL)
S Louis Bridges
(SL)
Debbie Campbell
(D)
Hayley L Carr
(HL)
Adam Chicoine
(A)
Andrew Cordle
(A)
Patrick Dunn
(P)
Lindsy Forbess
(L)
Peter K Gregersen
(PK)
Joel M Guthridge
(JM)
Lionel B Ivashkiv
(LB)
Kazuyoshi Ishigaki
(K)
Judith A James
(JA)
Gregory Keras
(G)
Ilya Korsunsky
(I)
Amit Lakhanpal
(A)
James A Lederer
(JA)
Zhihan J Li
(ZJ)
Yuhong Li
(Y)
Andrew McDavid
(A)
Mandy J McGeachy
(MJ)
Karim Raza
(K)
Yakir Reshef
(Y)
Christopher Ritchlin
(C)
William H Robinson
(WH)
Saori Sakaue
(S)
Jennifer A Seifert
(JA)
Anvita Singaraju
(A)
Melanie H Smith
(MH)
Dagmar Scheel-Toellner
(D)
Paul J Utz
(PJ)
Michael H Weisman
(MH)
Aaron Wyse
(A)
Zhu Zhu
(Z)
Informations de copyright
© 2023. The Author(s).
Références
Gravallese, E. M. & Firestein, G. S. Rheumatoid arthritis—common origins, divergent mechanisms. N. Engl. J. Med. 388, 529–542 (2023).
pubmed: 36780677
doi: 10.1056/NEJMra2103726
Alivernini, S., Laria, A., Gremese, E., Zoli, A. & Ferraccioli, G. ACR70-disease activity score remission achievement from switches between all the available biological agents in rheumatoid arthritis: a systematic review of the literature. Arthritis Res. Ther. 11, R163 (2009).
pubmed: 19886983
pmcid: 3003527
doi: 10.1186/ar2848
Alamanos, Y., Voulgari, P. V. & Drosos, A. A. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin. Arthritis Rheum. 36, 182–188 (2006).
pubmed: 17045630
doi: 10.1016/j.semarthrit.2006.08.006
Viatte, S. & Barton, A. Genetics of rheumatoid arthritis susceptibility, severity, and treatment response. Semin. Immunopathol. 39, 395–408 (2017).
pubmed: 28555384
pmcid: 5486781
doi: 10.1007/s00281-017-0630-4
Oliver, J., Plant, D., Webster, A. P. & Barton, A. Genetic and genomic markers of anti-TNF treatment response in rheumatoid arthritis. Biomark. Med. 9, 499–512 (2015).
pubmed: 26079957
doi: 10.2217/bmm.15.18
Lewis, M. J. et al. Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes. Cell Rep. 28, 2455–2470.e5 (2019).
pubmed: 31461658
pmcid: 6718830
doi: 10.1016/j.celrep.2019.07.091
Humby, F. et al. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. Lancet 397, 305–317 (2021).
pubmed: 33485455
pmcid: 7829614
doi: 10.1016/S0140-6736(20)32341-2
Zhang, F. et al. Defining inflammatory cell states inrheumatoid arthritis joint synovial tissues by integrating single-celltranscriptomics and mass cytometry. Nat. Immunol. 20, 928–942 (2019).
pubmed: 31061532
pmcid: 6602051
doi: 10.1038/s41590-019-0378-1
Kuo, D. et al. HBEGF
pubmed: 31068444
pmcid: 6726376
doi: 10.1126/scitranslmed.aau8587
Zhang, F. et al. IFN-γ and TNF-α drive a CXCL10
pubmed: 33879239
pmcid: 8057009
doi: 10.1186/s13073-021-00881-3
Rao, D. A. et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature 542, 110–114 (2017).
pubmed: 28150777
pmcid: 5349321
doi: 10.1038/nature20810
Alivernini, S. et al. Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. Nat. Med. 26, 1295–1306 (2020).
pubmed: 32601335
doi: 10.1038/s41591-020-0939-8
Wang, Y. et al. Rheumatoid arthritis patients display B-cell dysregulation already in the naïve repertoire consistent with defects in B-cell tolerance. Sci Rep. 9, 1–13 (2019).
doi: 10.1038/s41598-019-56279-0
Wei, K. et al. Notch signalling drives synovial fibroblast identity and arthritis pathology. Nature 582, 259–264 (2020).
pubmed: 32499639
pmcid: 7841716
doi: 10.1038/s41586-020-2222-z
Simmons, D. P. et al. SLAMF7 engagement superactivates macrophages in acute and chronic inflammation. Sci. Immunol. 7, eabf2846 (2022).
pubmed: 35148199
pmcid: 8991457
doi: 10.1126/sciimmunol.abf2846
Jonsson, A. H. et al. Granzyme K
pubmed: 35704599
pmcid: 9972878
doi: 10.1126/scitranslmed.abo0686
Marks, K. E. & Rao, D. A. T peripheral helper cells in autoimmune diseases. Immunol. Rev. 307, 191–202 (2022).
pubmed: 35103314
pmcid: 9009135
doi: 10.1111/imr.13069
Kochi, Y. Genetics of autoimmune diseases: perspectives from genome-wide association studies. Int. Immunol. 28, 155–161 (2016).
pubmed: 26857735
pmcid: 4889885
doi: 10.1093/intimm/dxw002
Dominguez-Villar, M. & Hafler, D. A. Regulatory T cells in autoimmune disease. Nat. Immunol. 19, 665–673 (2018).
pubmed: 29925983
pmcid: 7882196
doi: 10.1038/s41590-018-0120-4
Yuseff, M.-I. et al. Polarized secretion of lysosomes at the B cell synapse couples antigen extraction to processing and presentation. Immunity 35, 361–374 (2011).
pubmed: 21820334
doi: 10.1016/j.immuni.2011.07.008
Rubtsov, A. V. et al. CD11c-expressing B cells are located at the T cell/B cell border in spleen and are potent APCs. J. Immunol. 195, 71–79 (2015).
pubmed: 26034175
doi: 10.4049/jimmunol.1500055
Radtke, D. & Bannard, O. Expression of the plasma cell transcriptional regulator Blimp-1 by dark zone germinal center B cells during periods of proliferation. Front. Immunol. 9, 3106 (2018).
pubmed: 30687317
doi: 10.3389/fimmu.2018.03106
Weyand, C. M. & Goronzy, J. J. Ectopic germinal center formation in rheumatoid synovitis. Ann. N. Y. Acad. Sci. 987, 140–149 (2003).
pubmed: 12727633
doi: 10.1111/j.1749-6632.2003.tb06042.x
Ebbo, M., Crinier, A., Vély, F. & Vivier, E. Innate lymphoid cells: major players in inflammatory diseases. Nat. Rev. Immunol. 17, 665–678 (2017).
pubmed: 28804130
doi: 10.1038/nri.2017.86
Gordon, S. Phagocytosis: an immunobiologic process. Immunity 44, 463–475 (2016).
pubmed: 26982354
doi: 10.1016/j.immuni.2016.02.026
Jakubzick, C. V., Randolph, G. J. & Henson, P. M. Monocyte differentiation and antigen-presenting functions. Nat. Rev. Immunol. 17, 349–362 (2017).
pubmed: 28436425
doi: 10.1038/nri.2017.28
Lim, H. Y. et al. Hyaluronan receptor LYVE-1-expressing macrophages maintain arterial tone through hyaluronan-mediated regulation of smooth muscle cell collagen. Immunity 49, 326–341.e7 (2018).
pubmed: 30054204
doi: 10.1016/j.immuni.2018.06.008
Schuch, K. et al. Osteopontin affects macrophage polarization promoting endocytic but not inflammatory properties. Obesity 24, 1489–1498 (2016).
pubmed: 27221527
doi: 10.1002/oby.21510
Remmerie, A. et al. Osteopontin expression identifies a subset of recruited macrophages distinct from kupffer cells in the fatty liver. Immunity 53, 641–657.e14 (2020).
pubmed: 32888418
pmcid: 7501731
doi: 10.1016/j.immuni.2020.08.004
Villani, A.-C. et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science 356, eaah4573 (2017).
pubmed: 28428369
pmcid: 5775029
doi: 10.1126/science.aah4573
Zhang, Q. et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell 179, 829–845.e20 (2019).
pubmed: 31675496
doi: 10.1016/j.cell.2019.10.003
Mizoguchi, F. et al. Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. Nat. Commun. 9, 789 (2018).
pubmed: 29476097
pmcid: 5824882
doi: 10.1038/s41467-018-02892-y
Korsunsky, I. et al. Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases. Med 3, 481–518 (2022).
pubmed: 35649411
doi: 10.1016/j.medj.2022.05.002
Buechler, M. B. et al. Cross-tissue organization of the fibroblast lineage. Nature 593, 575–579 (2021).
pubmed: 33981032
doi: 10.1038/s41586-021-03549-5
Wigle, J. T. et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 21, 1505–1513 (2002).
pubmed: 11927535
pmcid: 125938
doi: 10.1093/emboj/21.7.1505
Fujimoto, N. et al. Single-cell mapping reveals new markers and functions of lymphatic endothelial cells in lymph nodes. PLoS Biol. 18, e3000704 (2020).
pubmed: 32251437
pmcid: 7162550
doi: 10.1371/journal.pbio.3000704
Wang, S. et al. IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c
pubmed: 29717110
pmcid: 5931508
doi: 10.1038/s41467-018-03750-7
Schröder, A. E., Greiner, A., Seyfert, C. & Berek, C. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc. Natl Acad. Sci. USA. 93, 221–225 (1996).
pubmed: 8552609
pmcid: 40210
doi: 10.1073/pnas.93.1.221
Scheel, T., Gursche, A., Zacher, J., Häupl, T. & Berek, C. V-region gene analysis of locally defined synovial B and plasma cells reveals selected B cell expansion and accumulation of plasma cell clones in rheumatoid arthritis. Arthritis Rheum. 63, 63–72 (2011).
pubmed: 20882667
doi: 10.1002/art.27767
Andersen, M. et al. Ultrasound colour Doppler is associated with synovial pathology in biopsies from hand joints in rheumatoid arthritis patients: a cross-sectional study. Ann. Rheum. Dis. 73, 678–683 (2014).
pubmed: 23475981
doi: 10.1136/annrheumdis-2012-202669
Romão, V. C. et al. Treatment-resistant synovitis and radiographic progression are increased in elderly-onset rheumatoid arthritis patients: findings from a prospective observational longitudinal early arthritis cohort study. Semin. Arthritis Rheum. 50, 735–743 (2020).
pubmed: 32531503
doi: 10.1016/j.semarthrit.2020.03.018
Just, S. A. et al. Six-month prospective trial in early and long-standing rheumatoid arthritis: evaluating disease activity in the wrist through sequential synovial histopathological analysis, RAMRIS magnetic resonance score and EULAR-OMERACT ultrasound score. RMD Open 5, e000951 (2019).
pubmed: 31413866
pmcid: 6667976
doi: 10.1136/rmdopen-2019-000951
Kroot, E. J. et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 43, 1831–1835 (2000).
pubmed: 10943873
doi: 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6
Rivellese, F. et al. Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial. Nat. Med. 28, 1256–1268 (2022).
pubmed: 35589854
pmcid: 9205785
doi: 10.1038/s41591-022-01789-0
Ishigaki, K. et al. Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis. Nat. Genet. 54, 1640–1651 (2022).
pubmed: 36333501
pmcid: 10165422
doi: 10.1038/s41588-022-01213-w
Saevarsdottir, S. et al. Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset. Ann. Rheum. Dis. 81, 1085–1095 (2022).
pubmed: 35470158
doi: 10.1136/annrheumdis-2021-221754
Zhao, H., Li, M., Ouyang, Q., Lin, G. & Hu, L. VEGF promotes endothelial cell differentiation from human embryonic stem cells mainly through PKC-ɛ/η pathway. Stem Cells Dev. 29, 90–99 (2020).
pubmed: 31752619
doi: 10.1089/scd.2019.0172
van Oosterhout, M. et al. Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis. Arthritis Rheum. 58, 53–60 (2008).
pubmed: 18163491
doi: 10.1002/art.23148
van Vollenhoven, R. F. & Klareskog, L. Clinical responses to tumor necrosis factor alpha antagonists do not show a bimodal distribution: data from the Stockholm tumor necrosis factor alpha followup registry. Arthritis Rheum. 48, 1500–1503 (2003).
pubmed: 12794816
doi: 10.1002/art.11027